Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, René Bernards, Sara Mainardi et al.|Cell Reports Medicine|2024Cited by 34
CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinomaYang Wu, Haojie Jin, Shuo Lian et al.|Proceedings of the National Academy of Sciences|2025Cited by 1